Atul Varadhachary

1.4k total citations
28 papers, 1.1k citations indexed

About

Atul Varadhachary is a scholar working on Nutrition and Dietetics, Oncology and Surgery. According to data from OpenAlex, Atul Varadhachary has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nutrition and Dietetics, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in Atul Varadhachary's work include Infant Nutrition and Health (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Bacterial Genetics and Biotechnology (5 papers). Atul Varadhachary is often cited by papers focused on Infant Nutrition and Health (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Bacterial Genetics and Biotechnology (5 papers). Atul Varadhachary collaborates with scholars based in United States, India and Italy. Atul Varadhachary's co-authors include Peter C. Maloney, Federica Pericle, Michela Spadaro, Gonzalo de la Rosa, Poonam Tewary, Joost J. Oppenheim, De Yang, Guido Forni, Suresh V. Ambudkar and Larry A. Sonna and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Atul Varadhachary

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Atul Varadhachary

Since Specialization

Citations

This map shows the geographic impact of Atul Varadhachary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Varadhachary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Varadhachary more than expected).

Fields of papers citing papers by Atul Varadhachary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul Varadhachary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Varadhachary. The network helps show where Atul Varadhachary may publish in the future.

Co-authorship network of co-authors of Atul Varadhachary

This figure shows the co-authorship network connecting the top 25 collaborators of Atul Varadhachary. A scholar is included among the top collaborators of Atul Varadhachary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul Varadhachary. Atul Varadhachary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease 2018 ·Journal of Biological Chemistry ·John Knight, Pijus K. Mandal, Pietro Morlacchi, Garbo Mak, (unknown), Matthew C. Madison, Cameron Landers, (unknown), (unknown), Brian E. Gilbert, Joel M. Sederstrom, Atul Varadhachary, Melissa Singh, Dev Chatterjee, David B. Corry, John S. McMurray	22
2	Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands 2014 ·Frontiers in Pharmacology ·(unknown), David Goldblatt, (unknown), Mark F. Munsell, Lee J. Quinton, Adam K. Walker, Robert Dantzer, Atul Varadhachary, Brenton L. Scott, Scott E. Evans, Michael J. Tuvim, Burton F. Dickey	19
3	A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Raghunadharao Digumarti, (unknown), (unknown), Dinesh Chandra Doval, Suresh H. Advani, Pramod Kumar Julka, Purvish M. Parikh, Shekhar Patil, Shona Nag, Jayaprakash Madhavan, Ajay Bapna, (unknown), Atul Varadhachary, Rajesh Malik	59
4	Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors 2009 ·Investigational New Drugs ·Teresa G. Hayes, Gerald S. Falchook, Atul Varadhachary	20
5	Lactoferrin Acts as an Alarmin to Promote the Recruitment and Activation of APCs and Antigen-Specific Immune Responses 2008 ·The Journal of Immunology ·Gonzalo de la Rosa, De Yang, Poonam Tewary, Atul Varadhachary, Joost J. Oppenheim	163
6	Talactoferrin Stimulates Wound Healing With Modulation of Inflammation 2008 ·Journal of Surgical Research ·(unknown), Paul Blezinger, Atul Varadhachary	47
7	Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma 2008 ·Cancer ·Eric Jonasch, Walter M. Stadler, Ronald M. Bukowski, Teresa G. Hayes, Atul Varadhachary, Rajesh Malik, Robert A. Figlin, Sandy Srinivas	36
8	Effect of oral talactoferrin (TLF) on levels of cytokines involved in the Th1-mediated immune response in clinical studies 2008 ·Journal of Clinical Oncology ·(unknown), Raghunadharao Digumarti, (unknown), M Fodor, Karel Petrak, (unknown), Radek Malı́k, Atul Varadhachary	4
9	Requirement for IFN-γ, CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors 2007 ·Cancer Research ·Michela Spadaro, Claudia Curcio, Atul Varadhachary, Federica Cavallo, (unknown), Paul Blezinger, Federica Pericle, Guido Forni	30
10	C1-05: Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial 2007 ·Journal of Thoracic Oncology ·Purvish M. Parikh, (unknown), (unknown), Ashok K. Vaid, Suresh H. Advani, Raghunadharao Digumarti, (unknown), Jayaprakash Madhavan, Atul Varadhachary	2
11	Phase I trial of oral talactoferrin alfa in refractory solid tumors 2005 ·Investigational New Drugs ·Teresa G. Hayes, (unknown), Gauri R. Varadhachary, (unknown), (unknown), Hari M. Dhingra, (unknown), Atul Varadhachary	80
12	Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy 2004 ·International Journal of Cancer ·Atul Varadhachary, Jeffrey S. Wolf, Karel Petrak, Bert W. O’Malley, Michela Spadaro, Claudia Curcio, Guido Forni, Federica Pericle	104
13	Oral recombinant human Lactoferrin (rhLF) slows tumor growth in metastatic NSCLC and other advanced incurable cancers: Results of a Phase II study 2004 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Atul Varadhachary, (unknown)	3
14	Purification and identification of a fatty acyl-CoA synthetase from Trypanosoma brucei 2004 ·Molecular and Biochemical Parasitology ·D JIANG, Karl A. Werbovetz, Atul Varadhachary, Robert N. Cole, Paul T. Englund	3
15	Oral recombinant human Lactoferrin (rhLF) slows tumor growth in metastatic NSCLC and other advanced incurable cancers: Results of a Phase II study 2004 ·Journal of Clinical Oncology ·(unknown), Gauri R. Varadhachary, Gerald S. Falchook, Doug Smith, Atul Varadhachary, Hari M. Dhingra	4
16	A Point of Light in Mumbai 2001 ·The McKinsey Quarterly ·Rukmini Banerji, (unknown), (unknown), Atul Varadhachary	1
17	Identification of Two Essential Arginine Residues in UhpT, the Sugar Phosphate Antiporter of Escherichia coli 1998 ·The Journal of Membrane Biology ·(unknown), (unknown), Atul Varadhachary, Toshihiko Kuroda, Carolyn S. Sevier, Tomofusa Tsuchiya, Peter C. Maloney	37
18	Reconstitution of the phosphoglycerate transport protein of Salmonella typhimurium. 1991 ·Journal of Biological Chemistry ·Atul Varadhachary, Peter C. Maloney	10
19	A rapid method for reconstitution of bacterial membrane proteins 1990 ·Molecular Microbiology ·Atul Varadhachary, Peter C. Maloney	19
20	Anion-exchange mechanisms in bacteria 1990 ·Microbiological Reviews ·Peter C. Maloney, Suresh V. Ambudkar, (unknown), Larry A. Sonna, Atul Varadhachary	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact